![]() ![]() ![]() We were founded in 1988 and are headquartered in New York City. Our focus is on fostering the long-term success of our corporate clients through raising capital, providing strategic advisory services, generating insightful research, and developing institutional sponsorship by leveraging the firm’s sales, trading, and equity research capabilities. The Benchmark Company is an institutionally focused, research driven, sales trading and investment banking firm. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. We have 6 Clinical Sites around the United States - Austin, Ft. To ensure you are comparing yourself to the most relevant, comparable, and accessible competitors, consider the following criteria: Relevance - select competitors that target the same or similar. Industry leader, specializing in conduct of Investigational Vaccine Trials. Austin, FW, San Antonio, New Orleans, Sacramento, San Angelo, and L.A. Raising the Standard in Clinical Research. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Benchmark Research 2,171 followers on LinkedIn. To register for the conference, please visit To schedule a one-on-one meeting with Harvard Bioscience, Inc., you may submit your request online via the link provided upon registration. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer. They include the study methodology, the tasks, the screener, the definitions of the collected metrics, as well as the raw data obtained from the study. The conference offers emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Jim Green, Chairman and Chief Executive Officer, will be participating in one-on-one meetings with investors and analysts throughout the day. Summary: All the details of your benchmark study need to be stored in your research repository for further reference. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12Īnnual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York City. ![]() 20, 2023 (GLOBE NEWSWIRE) - Harvard Bioscience, Inc. Benchmark Research, an Avacare business, has a track record of safety and expertise, having conducted more than 1,000 trials since 1997 at clinics located in California, Louisiana and Texas. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |